Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC).
In the UK, there has been a rapid increase in the reclassification of prescription only medicines (POMs) to pharmacy only (P) and general sales list (GSL) status. This means that community pharmacy staff have a greater range of non-prescription medicines to recommend for the treatment of minor illness. Strategies are needed to promote good professional practice in the supply of non-prescription medicines. Guidelines have been shown to promote quality of care in other health care settings. In this article, we present evidence based guidelines for the treatment of vulvovaginal candidiasis using non-prescription anti-fungal medicines.
Watson
Margaret C
MC
Department of General Practice and Primary Care, University of Aberdeen, Westburn Road, AB25 2AY, Aberdeen, UK. m.c.watson@abdn.ac.uk
Bond
Christine M
CM
D000935:Antifungal Agents / Q000191:economics / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003157:Community Pharmacy Services / Q000592:standards; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D004366:Nonprescription Drugs / Q000191:economics / Q000627:therapeutic use*; D011785:Quality Assurance, Health Care; D012651:Self Medication; D006113:United Kingdom
D000935:Antifungal Agents; D004366:Nonprescription Drugs